2025 FA Symposium: Managing FA Together: Clinical Insights for Patients and Families (Session #2)

Speakers: David Lynch, MD, PhD, Shana McCormack, MD, MTR, and Kimberly Lin, MD   FARA's Mission is to marshal and focus the resources and relationships needed to cure Friedreich's Ataxia (FA) by raising funds for research, promoting public awareness, and aligning scientists, patients, clinicians, government agencies, pharmaceutical companies and other organizations dedicated to curing FA and related diseases. Friedreich’s Ataxia is a debilitating, life-shortening, degenerative neuro-muscular disorder. About one in 50,000 people in the United States have Friedreich's Ataxia. Subscribe to FARA's YouTube channel    / fara1998   Follow FARA on Facebook   / curefa   Follow FARA on Instagram   / curefa_org